Provider Alert! Addition of Bamlanivimab and Casirivimab/Imdevimab as a Texas Medicaid Benefit and for FDA Emergency Use Authorization
Attention: All Providers Effective Date: December 15, 2020 Providers should monitor the Texas Children’s Health Plan (TCHP) Provider Portal regularly for alerts and updates associated to the COVID-19 event. TCHP reserves the right to update and/or change this information without prior notice due to the evolving nature of the COVID-19 event. Call to action: Texas Children’s Health Plan would like to inform network providers that Texas Medicaid has added two medications, bamlanivimab and casirivimab/imdevimab, as outpatient benefits in response to the COVID-19 Emergency Use...